03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Venofer IV : | |
Type | Medicine Authorised |
Originator | B |
Agent | UPO |
Distributor | UPO |
Laboratory | Vifor |
Responsible Party | Vifor (International) Inc |
Origin | Switzerland |
Manufacturer | Takeda Austria GmbH |
Origin | Austria |
ATC | B03AC |
Venofer IV :
Venofer IV :
Venofer IV :
Venofer IV :
Venofer IV :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Venofer IV :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
ALT increased | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
AST increased | Not known |
Asthenia | Not known |
Back pain | Uncommon |
Blood creatinine increased | Rare |
Bradycardia | Not known |
Burning sensation | Uncommon |
Cephalea | Uncommon |
Chest pain | Rare |
Chills | Uncommon |
Chromaturia | Uncommon |
Collapse | Uncommon |
Constipation | Uncommon |
Diarrhoea (Diarrhea) | Uncommon |
Disturbances in consciousness | Not known |
Dry mouth (Xerostomia) | Rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspnoea (dyspnea) | Uncommon |
Fatigue | Uncommon |
Fever | Rare |
Gamma-GT increased | Uncommon |
Hyperhidrosis | Not known |
Hypersensitivity reactions | Uncommon |
Hypertension | Common |
Hypoesthesia | Uncommon |
Hypotension | Common |
Injection site burning | Uncommon |
Injection site discolouration | Uncommon |
Injection site extravasation | Uncommon |
Injection site haematoma | Rare |
Injection site irritation | Uncommon |
Injection site itching | Rare |
Injection site pain | Common |
Injection site reaction | Uncommon |
Injection site swelling | Uncommon |
Iron overload | Rare |
Lactic dehydrogenase increased | Rare |
Liver function test abnormal | Not known |
Migraine | Rare |
Muscle cramps | Uncommon |
Muscle spasms | Rare |
Muscular hypotonia | Not known |
Myalgia | Uncommon |
Nausea | Common |
Pain | Uncommon |
Pain in extremity (Pain in limb) | Uncommon |
Palpitations | Rare |
Paraesthesia (paresthesia) | Uncommon |
Phlebitis | Uncommon |
Pneumonia | Rare |
Polycythaemia | Uncommon |
Pruritus | Uncommon |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Rare |
Serum ferritin increased | Rare |
Skin Eruption | Uncommon |
Somnolence | Rare |
Superficial phlebothrombosis | Not known |
Syncope | Rare |
Tachycardia | Uncommon |
Thrombophlebitis | Uncommon |
Vertigo | Uncommon |
Vomiting | Uncommon |
Venofer IV :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Venofer IV MoH 10178 :
Form | Solution for injection |
Packaging | Ampoules |
Package Size | 5x5ml |
Strength | 100mg |
Storage Condition | 4-25°C Do not freeze |
Public Price | 3594914.33 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 102219/1 |
Submission date | 2019 |
Registration Year | 03/08/2020 |
Price Comparison
● Country: | Denmark | |
● Package Size: | 5x5ml | |
● Public Price: | 1008.85 DKK | ( 13,090,837.60 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 201,77 DKK | ( 2,608,176.00 LBP ) |
● Pharmacy Price: | 745 DKK | ( 9667120 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 5x5ml | |
● Public Price: | 19381 ISK | ( 12,500,745.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 3876,2 ISK | ( 2,500,020.00 LBP ) |
● Pharmacy Price: | 13019 ISK | ( 8397255 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 5x5ml | |
● Public Price: | 113.55 CHF | ( 11,743,341.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 22,71 CHF | ( 2,275,240.00 LBP ) |
● Exfactory Price: | 84.63 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 5x5ml | |
● Public Price: | 815.33 SEK | ( 6,855,294.64 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 163,066 SEK | ( 1,370,504.00 LBP ) |
● Pharmacy Price: | 754 SEK | ( 6339632 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 5x5ml | |
● Public Price: | 1592.66 CZK | ( 6,082,368.54 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 318,532 CZK | ( 1,214,442.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 5 | |
● Public Price: | 30.57 JOD | ( 3,828,005.97 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 6,114 JOD | ( 751,326.00 LBP ) |
● Pharmacy Price: | 23.32 JOD | ( 2920153.72 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 5x5ml | |
● Public Price: | 3594914.33 LBP | ( 3,594,914.33 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 718982,87 LBP | ( 718,982.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Turkey | |
● Package Size: | 5x5ml | |
● Public Price: | 110.47 TRY | ( 296,059.60 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 22,094 TRY | ( 58,960.00 LBP ) |
● Pricing Date: | 31/12/2019 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 5 inj |
● Exfactory Price: | 100 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
● Country: | Greece |
● Package Size: | 5x5ml |
● Reference: | National Organization for Medicines |
● Pricing Date: | 25/03/2019 |
● Type: | Medicine Non Marketed |
● Country: | Portugal |
● Package Size: | 5x5ml |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
Note
You have to register to view this info
Drop File